Kresnier Perez

Decentralized trials, often referred to as virtual or remote trials, represent a transformative shift in the landscape of clinical research. Unlike traditional clinical trials that typically require participants to visit centralized sites for assessments and interventions, decentralized trials leverage technology to facilitate patient participation from their homes or local healthcare facilities. This innovative approach has […]

The National Cancer Institute (NCI) plays a pivotal role in the landscape of cancer research, particularly through its extensive network of clinical trials. These trials are meticulously designed studies that evaluate new treatments, diagnostic methods, and preventive strategies for cancer. The NCI, as part of the National Institutes of Health (NIH), is dedicated to understanding

Risk-Based Monitoring (RBM) has emerged as a transformative approach in the realm of clinical trials, fundamentally altering how researchers and sponsors manage the complexities of trial oversight. Traditional monitoring methods often involve a one-size-fits-all strategy, which can lead to inefficiencies and resource wastage. In contrast, RBM focuses on identifying and mitigating risks that could impact

Patient outcomes are the cornerstone of clinical trials, serving as the ultimate measure of a treatment’s efficacy and safety. These outcomes encompass a wide range of metrics, including symptom relief, quality of life, and overall survival rates. The significance of patient outcomes extends beyond mere statistical analysis; they reflect the real-world impact of medical interventions

Clinical trial feasibility is a critical component in the planning and execution of clinical research. It encompasses the assessment of various factors that determine whether a clinical trial can be successfully conducted at a specific site or within a particular population. This process involves evaluating the logistical, operational, and regulatory aspects that could impact the

Pharmaron is a prominent global provider of integrated research and development services for the pharmaceutical and biotechnology industries. Established with the mission to accelerate drug discovery and development, Pharmaron has become a key player in the realm of clinical trials. These trials are essential for evaluating the safety and efficacy of new drugs before they

The European Union Clinical Trial Register (EU CTR) serves as a pivotal resource in the landscape of medical research, providing a comprehensive database of clinical trials conducted across Europe. Established to enhance transparency and accessibility, the EU CTR allows stakeholders—including researchers, healthcare professionals, and patients—to access detailed information about ongoing and completed clinical trials. This